Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates (Q40339968)

19 September 2017

Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates (English)

1 reference

19 September 2017

1 reference

6

1 reference

19 September 2017

9

Kordower J

1 reference

19 September 2017

Behrstock S

1

1 reference

19 September 2017

Ebert A

2

1 reference

19 September 2017

McHugh J

3

1 reference

19 September 2017

Vosberg S

4

1 reference

19 September 2017

Moore J

5

1 reference

19 September 2017

Capowski E

7

1 reference

19 September 2017

Hei D

8

1 reference

19 September 2017

Aebischer P

10

1 reference

19 September 2017

Svendsen CN

11

1 reference

19 September 2017

language of work or name

1 reference

1 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

5

1 reference

19 September 2017

379-388

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302679

19 September 2017

0 references

cites work

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Dopaminergic neurons protected from degeneration by GDNF gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Critical issues in gene therapy for neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Gene therapy and cell transplantation for Alzheimer's disease and spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

A new method for the rapid and long term growth of human neural precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Gene expression in human neural stem cells: effects of leukemia inhibitory factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Human neural stem cell transplants improve motor function in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Transplantation of human neural progenitor cells into the neonatal rat brain: extensive migration and differentiation with long-distance axonal projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Combining growth factors, stem cells, and gene therapy for the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

GDNF delivery using human neural progenitor cells in a rat model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Mouse epidermal growth factor-responsive neural precursor cells increase the survival and functional capacity of embryonic rat dopamine neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

The GDNF family: signalling, biological functions and therapeutic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Preserving the genetic integrity of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Human embryonic stem cells express an immunogenic nonhuman sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

7 January 2021

Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

7 January 2021

Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

7 January 2021

Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302679

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302679

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference